Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Cash, cash equivalents and marketable securities as of September 30, 2025 totaled $4.1 million, compared to $27.6 million for t...
Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands and...
HC Wainwright & Co. analyst Brandon Folkes assumes Rani Therapeutics Hldgs (NASDAQ:RANI) with a Buy rating and announces...
